National Peroxide Ltd Quality Grade Upgrade Signals Mixed Business Fundamentals

Quality Grade Upgrade and Market Context

On 7 May 2025, National Peroxide Ltd’s quality grade was upgraded from Strong Sell to Sell, with the Mojo Score rising to 31.0. This upgrade reflects a modest improvement in the company’s fundamental parameters, particularly in quality metrics. The company operates within the Commodity Chemicals sector, a space characterised by cyclical demand and pricing pressures. Despite this, National Peroxide’s stock price has shown resilience, closing at ₹424.30 on 9 February 2026, up 3.65% on the day, though still significantly below its 52-week high of ₹770.00.

Sales and Earnings Growth: A Lingering Concern

One of the most glaring weaknesses remains the company’s sales and earnings trajectory. Over the past five years, National Peroxide has experienced a compounded annual sales decline of 12.6%, while EBIT has plummeted by an alarming 135.58%. Such negative growth rates highlight ongoing operational challenges and market headwinds that have constrained revenue generation and profitability. This deterioration in core earnings metrics continues to weigh heavily on investor sentiment and valuation.

Return Ratios: ROE and ROCE Analysis

Return on Equity (ROE) and Return on Capital Employed (ROCE) are critical indicators of how efficiently a company utilises shareholder funds and capital to generate profits. National Peroxide’s average ROE stands at a modest 1.90%, while its average ROCE is slightly higher at 3.99%. Both ratios are considerably below industry averages and reflect subdued profitability. However, these figures have shown relative stability compared to previous periods, suggesting that while returns remain low, the company is managing to maintain a baseline level of operational efficiency.

Debt and Interest Coverage: Signs of Financial Prudence

On the debt front, National Peroxide exhibits a conservative profile. The average Debt to EBITDA ratio is 0.66, indicating manageable leverage levels. Moreover, the company’s EBIT to Interest coverage ratio averages 2.98, signalling that earnings comfortably cover interest obligations nearly threefold. Net debt to equity remains at zero on average, underscoring a debt-free or net cash position. This low leverage reduces financial risk and provides flexibility to navigate market volatility, a positive factor in the company’s quality assessment.

Operational Efficiency and Capital Utilisation

Sales to Capital Employed ratio, a measure of asset utilisation efficiency, averages 0.87 for National Peroxide. This figure suggests that the company generates less than a rupee of sales for every rupee of capital employed, indicating suboptimal capital productivity. While this ratio is not alarming, it points to room for improvement in asset management and operational scaling to enhance returns.

Dividend Policy and Shareholding Structure

National Peroxide maintains a dividend payout ratio of 42.79%, reflecting a moderate commitment to returning cash to shareholders despite earnings pressures. Institutional holding is minimal at 0.01%, and pledged shares stand at zero, indicating limited promoter encumbrance and a relatively stable ownership structure. These factors contribute positively to the company’s governance and investor confidence.

Comparative Industry Positioning

Within the Commodity Chemicals sector, National Peroxide’s quality grade now aligns with several peers such as Stallion India, TGV Sraac, Amines & Plastics, and Fairchem Organic, all rated as average. This upgrade places National Peroxide ahead of companies like Oriental Aromatics, which remains below average, and Gem Aromatics, which does not qualify for a quality rating. The company’s market cap grade is 4, reflecting its micro-cap status, which often entails higher volatility and risk but also potential for growth if fundamentals improve.

Stock Performance Relative to Sensex

National Peroxide’s stock returns have lagged the broader market significantly. Over the past year, the stock has declined by 40.66%, while the Sensex gained 7.07%. Year-to-date, the stock is down 9.34% compared to a 1.92% decline in the Sensex. Even over shorter periods such as one month and one week, the stock’s performance has been mixed, with a slight outperformance in the last week (+6% vs. Sensex +1.59%) but underperformance over one month (-1.26% vs. Sensex -1.74%). This volatility reflects the underlying fundamental challenges and market sentiment.

Outlook and Investment Considerations

While the upgrade in quality grade from below average to average is a positive development, it is important to contextualise this within the broader financial picture. The company’s persistent negative sales and EBIT growth, coupled with low returns on capital, suggest that operational turnaround remains a work in progress. However, the conservative debt profile and stable dividend policy provide some cushion against downside risks.

Investors should weigh the company’s improved quality metrics against its valuation and sector dynamics. The current Mojo Grade of Sell indicates caution, reflecting that while some fundamentals have improved, significant challenges remain. For those considering exposure to the Commodity Chemicals sector, National Peroxide may warrant a watchful approach, particularly in comparison to stronger peers.

Conclusion: A Measured Improvement Amidst Lingering Challenges

National Peroxide Ltd’s upgrade in quality grade to average marks a tentative step forward in its fundamental assessment. The company’s financial prudence, reflected in low debt and adequate interest coverage, contrasts with its ongoing struggles in sales and earnings growth. Return ratios remain subdued, underscoring the need for operational improvements to drive shareholder value.

For investors, the current Sell rating and modest Mojo Score suggest that while the company is no longer in the weakest category, it still faces significant hurdles. Monitoring future quarterly results for signs of revenue stabilisation and margin expansion will be critical. Until then, National Peroxide remains a cautious proposition within the Commodity Chemicals sector.

Unlock special upgrade rates for a limited period. Start Saving Now →